CARSGEN THERAPEUTICS HLDGS LTD
(HKEX: 2171)
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The firm focuses on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company was founded by Zong Hai Li and Hua Mao Wang on February 9, 2018, and is headquartered in Shanghai, China.
18.180 -
-0.080
(-0.44%)
Range
17.900 - 18.500
(3.35%)
Open
18.290
Previous Close
18.260
Bid Price
18.180
Bid Volume
('000)
4.5
Ask Price
18.200
Ask Volume
('000)
0.5
Volume
('000)
1,238.5
Value
22,593,940
Remark
-
Delayed prices. Updated at 05 Dec 2025 16:09.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
